Racial and ethnic disparities in eligibility for postpartum venous thromboembolism prophylaxis in the United States

ISTH Academy, , 410504

Management of anticoagulation and factor XIII replacement in a patient with severe factor XIII deficiency and recurrent venous thromboembolic disease: case report and review of literature

ISTH Academy, Faculty / Presenters, 417439

Thrombocytopenia with and without thrombosis following COVID-19 vaccination: long-term management

ISTH Academy, Lana Castellucci, 417438

Noninterventional study assessing joint health in persons with hemophilia A after switching to turoctocog alfa pegol: design of pathfinderReal

ISTH Academy, Faculty / Presenters, 417437

Ultrasound in addition to clinical assessment of acute musculoskeletal complaints in bleeding disorders: impact on patient management

ISTH Academy, Faculty / Presenters, 417434

Plasma tissue factor activity in lung cancer patients predicts venous thromboembolism and poor overall survival

ISTH Academy, Faculty / Presenters, 417432

Long-term outcomes with emicizumab in hemophilia A without inhibitors: results from the HAVEN 3 and 4 studies

ISTH Academy, Faculty / Presenters, 417428

Hepatocyte growth factor and risk of incident stroke in Black and White Americans in the Reasons for Geographic and Racial Differences in Stroke study

ISTH Academy, , 417427

Nonacog beta pegol prophylaxis in children with hemophilia B: safety, efficacy, and neurodevelopmental outcomes for up to 8 years

ISTH Academy, Faculty / Presenters, 417426

Exploring pregnant individuals’ counseling needs regarding urgent imaging to rule out pulmonary embolism

ISTH Academy, Isabelle Malhame, 417425

Platelet RNA sequencing reveals profile of caffeic acid affecting hemostasis in mice

ISTH Academy, Yu Hu, 417424

Oral anticoagulation for stroke prevention in atrial fibrillation and advanced kidney disease

ISTH Academy, , 417418

Proportion of venous thromboembolism attributed to recognized prothrombotic genotypes in men and women

ISTH Academy, Faculty / Presenters, 417417

The imperative to prevent joint bleeding in everyone living with hemophilia

ISTH Academy, Leonard Valentino, 417414

Inositol 1,3,4,5-tetrakisphosphate: a remarkable second messenger in platelet signaling

ISTH Academy, , 417412

Reply to the letter to the editor regarding “Defining heparin resistance: communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis”

ISTH Academy, Faculty / Presenters, 410510

“Defining Heparin Resistance: Communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis”: comment from Gouin-Thibault et al.

ISTH Academy, Faculty / Presenters, 410509

Uncertainties about the roles of anticoagulation and microclots in post-acute sequelae of SARS-CoV-2 infection—response to the letter by Kell et al.

ISTH Academy, , 410508

A novel leukocyte adhesion deficiency type III mutation manifests functional importance of the compact FERM domain in kindlin-3

ISTH Academy, Jordan Shavit, 410506

Antiplatelet drugs do not protect from platelet-leukocyte aggregation in coronary artery disease

ISTH Academy, , 410505

Efficacy and safety of direct oral anticoagulants in splanchnic vein thrombosis: a pooled analysis of literature studies

ISTH Academy, Matteo Di Minno, 410503

Incidence of venous thromboembolism, recurrence, and bleeding after isolated superficial vein thrombosis: findings from the Venous Thrombosis Registry in Østfold Hospital

ISTH Academy, Faculty / Presenters, 410502

Association between severity of pulmonary embolism and health-related quality of life

ISTH Academy, Faculty / Presenters, 410501

Open ADAMTS-13 conformation index predicts earlier relapse in immune-mediated thrombotic thrombocytopenic purpura

ISTH Academy, Karen Vanhoorelbeke, 410499

Whole blood thrombin generation shows a significant hypocoagulable state in patients with decompensated cirrhosis

ISTH Academy, Paolo Simioni, 410498

Alterations in the von Willebrand factor/ADAMTS-13 axis in preeclampsia

ISTH Academy, Faculty / Presenters, 410495

A bispecific antibody NXT007 exerts a hemostatic activity in hemophilia A monkeys enough to keep a nonhemophilic state

ISTH Academy, Faculty / Presenters, 410493

Comparison of direct oral anticoagulants versus low-molecular-weight heparin in primary and metastatic brain cancers: a meta-analysis and systematic review

ISTH Academy, Rushad Patell, 410492

In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency

ISTH Academy, Elisabetta Castoldi, 410491

Glycolytic reprogramming fuels myeloid cell-driven hypercoagulability

ISTH Academy, Roger Preston, 410490

Heterozygosity in factor XIII genes and the manifestation of mild inherited factor XIII deficiency

ISTH Academy, Arijit Biswas, 410489

Importance of early career professionals in the SSC of the ISTH

ISTH Academy, Faculty / Presenters, 410479

Finding a fountain of youth in the blood

ISTH Academy, Robert Campbell, 410480

What do we know about why women bleed and what do we not know?

ISTH Academy, Faculty / Presenters, 410481

Trauma-induced innate immune activation and disseminated intravascular coagulation

ISTH Academy, Faculty / Presenters, 410483

Hemophilia A treatment innovation: factor VIII mimetic bispecific antibodies—generational enhancement

ISTH Academy, Faculty / Presenters, 410484

Thrombin generation in cirrhosis: whole blood, whole truth?

ISTH Academy, Mattias Mandorfer, 410485

Postpulmonary embolism syndrome: what should we focus on?

ISTH Academy, , 410487

Clinical care of pediatric patients with or at risk of postthrombotic syndrome: guidance from the ISTH SSC Subcommittee on pediatric and neonatal thrombosis and hemostasis

ISTH Academy, Ayesha Zia, 410488

Microfluidics Devices in Hemostasis / Point-of-care Testing

ISTH Academy, Faculty / Presenters, 408333

Evaluation of laboratory testing parameters for vaccine-induced immune thrombotic thrombocytopenia and their implications for diagnosis

ISTH Academy, Ishac Nazy, 409391

Reversal of factor XI targeting anticoagulants: an in vitro evaluation

ISTH Academy, Joost Meijers, 409390

COVID-19 promotes endothelial dysfunction and thrombogenicity: role of proinflammatory cytokines/SGLT2 prooxidant pathway

ISTH Academy, , 409389

Trivalent nanobody-based ligands mediate powerful activation of GPVI, CLEC-2, and PEAR1 in human platelets whereas FcγRIIA requires a tetravalent ligand

ISTH Academy, Steve Watson, 409388

Thrombin-activatable fibrinolysis inhibitor and sex modulate thrombus stability and pulmonary embolism burden in a murine model

ISTH Academy, Paul Kim, 409387

Availability of medical and endovascular therapies for venous thromboembolism: a global survey for World Thrombosis Day

ISTH Academy, Stefano Barco, 409386

PI3KC2α inhibition is antithrombotic in blood from hypercholesterolemic mice

ISTH Academy, Justin Hamilton, 409385

Development and validation of a clinical prediction model for 90-day venous thromboembolism risk following total hip and total knee arthroplasty: a multinational study

ISTH Academy, , 409384

High molecular weight kininogen interactions with the homologs prekallikrein and factor XI: importance to surface-induced coagulation

ISTH Academy, David Gailani, 409383

Antithrombin activity and central venous catheter-associated thrombosis in critically ill children at high risk of bleeding

ISTH Academy, E. Vincent Faustino, 409382

ISTH News and Updates: Join the ISTH Today

ISTH Academy, Faculty / Presenters, 409392

Neutrophil extracellular traps induce persistent lung tissue damage via thromboinflammation without altering virus resolution in a mouse coronavirus model

ISTH Academy, Philipp Hohensinner, 409380

Platelets and neutrophils cooperate to induce increased neutrophil extracellular trap formation in JAK2V617F myeloproliferative neoplasms

ISTH Academy, Chloé James, 409379

Functional capacity and dyspnea during follow-up after acute pulmonary embolism

ISTH Academy, Stavros Konstantinides, 409378

Patients with moderate hemophilia A and B with a severe bleeding phenotype have an increased burden of disease

ISTH Academy, Saskia Schols, 409377

Doing more with less: low-titer group O whole blood resulted in less total transfusions and an independent association with survival in adults with severe traumatic hemorrhage

ISTH Academy, Faculty / Presenters, 409376

Fluorescent peptide for detecting factor XIIIa activity and fibrin in whole blood clots forming under flow

ISTH Academy, Scott L. Diamond, 412443

Venous thromboembolism, chronic liver disease and anticoagulant choice: effectiveness and safety of direct oral anticoagulants versus warfarin

ISTH Academy, , 412444

von Willebrand factor Ristocetin co-factor activity to von Willebrand factor antigen level ratio for diagnosis of acquired von Willebrand syndrome caused by aortic stenosis

ISTH Academy, Hisanori Horiuchi, 412445

Association of laboratory test results with the bleeding history in patients with inherited platelet function disorders (the Bleeding Assesment Tool - LABoratory tests substudy): communication from the Platelet Physiology ISTH-SSC

ISTH Academy, Faculty / Presenters, 412449

Exploring the ex vivo effects of Naja mossambica venom on the ultrastructure and viscoelastic properties of human blood

ISTH Academy, Janette Bester, 412450

Pharmacokinetics and coagulation biomarkers in children and adults with hemophilia A receiving emicizumab prophylaxis every 1, 2, or 4 weeks

ISTH Academy, Faculty / Presenters, 412451

Acute ischemic stroke and measurement of apixaban and rivaroxaban: an observational cohort implementation study

ISTH Academy, , 412452

Tissue factor pathway-related biomarkers in liver cancer: activated factor VII–antithrombin complex and tissue factor mRNA levels are associated with mortality

ISTH Academy, Simonetta Friso, 412453

Periodontitis in ischemic stroke: impact of Porphyromonas gingivalis on thrombus composition and ischemic stroke outcomes

ISTH Academy, Faculty / Presenters, 412454

Site-directed mutagenesis of tissue factor pathway inhibitor–binding exosite D60A on factor VII results in a new factor VII variant with lower coagulant activity

ISTH Academy, Pansakorn Tanratana, 412455

The impact of child-specific characteristics on warfarin dosing requirements

ISTH Academy, Faculty / Presenters, 412456

Validation of a fibrinogen γ’ enzyme-linked immunosorbent assay using a new monoclonal antibody: effects of bariatric surgery

ISTH Academy, Faculty / Presenters, 412457

Contractility defects hinder glycoprotein VI-mediated platelet activation and affect platelet functions beyond clot contraction

ISTH Academy, Ingmar Schoen, 412458

Bleeding events in thrombotic antiphospholipid syndrome: prevalence, severity, and associated damage accrual

ISTH Academy, Faculty / Presenters, 412459

Neutrophil-dependent hepatic platelet accumulation and liver injury revealed by acetaminophen dose-response studies

ISTH Academy, James Luyendyk, 412460

Primary prevention of venous thromboembolism for cancer patients in randomized controlled trials: a bibliographical analysis of funding and trial characteristics

ISTH Academy, , 412461

Evidence that inositol 1,4,5-trisphosphate 3-kinase and inositol 1,3,4,5-tetrakisphosphate are negative regulators of platelet function

ISTH Academy, Faculty / Presenters, 412462

Anticoagulation in atrial fibrillation and end-stage kidney disease on hemodialysis: a meta-analysis of randomized trials comparing direct oral anticoagulants with vitamin K antagonists

ISTH Academy, , 412464

Impact of thrombosis location on walking capacity: a cohort study of patients with acute deep vein thrombosis

ISTH Academy, , 412465

Clot formation and fibrinolysis assays reveal functional differences among hemostatic agents in hemophilia A plasma

ISTH Academy, Alisa Wolberg, 412466

Acquired hemophilia A: a single-center study of 165 patients

ISTH Academy, Lei Zhang, 412467

Procedural outcomes in children with mild type 1 von Willebrand disease

ISTH Academy, Megan C. Brown, 412468

Efficacy and safety of antithrombin supplementation in neonates and infants on a continuous heparin infusion

ISTH Academy, Patricia Davenport, 412469

Thrombosis in patients with immune thrombocytopenia: incidence, risk, and clinical outcomes

ISTH Academy, Faculty / Presenters, 412470

Pulmonary embolism risk stratification: external validation of the 4-level Clinical Pretest Probability Score (4PEPS)

ISTH Academy, Grégoire Le Gal, 412471

Platelets from patients with chronic inflammation have a phenotype of chronic IL-1β release

ISTH Academy, , 412472

Hemophagocytic lymphohistiocytosis is associated with deficiency and closed conformation of ADAMTS-13

ISTH Academy, Bérangère S Joly, 412473

Hematologic characteristics and coagulopathy in pregnancy with COVID-19 succeeding the first wave: a multicenter retrospective cross-sectional study

ISTH Academy, Faculty / Presenters, 412474

A novel factor IXa–specific enzyme-linked immunosorbent assay detects factor IXa in human plasma

ISTH Academy, Faculty / Presenters, 412475

Desmopressin to prevent and treat bleeding in pregnant women with an inherited bleeding disorder: a systematic literature review

ISTH Academy, Faculty / Presenters, 409375

Thrombin generation on vascular cells in the presence of factor VIII and/or emicizumab

ISTH Academy, Faculty / Presenters, 409374

The necessity of repeat testing for von Willebrand disease in adult patients with mild to moderate bleeding disorders

ISTH Academy, Johanna Gebhart, 409373

Evaluation of collagen turnover biomarkers as an objective measure for efficacy of treatment with rurioctocog alfa pegol in patients with hemophilia A: a secondary analysis of a randomized controlled trial

ISTH Academy, Faculty / Presenters, 409372

Mice possess a more limited natural antihuman factor VIII antibody repertoire than humans that is produced disproportionately by marginal zone B cells

ISTH Academy, David Lillicrap, 409371

COVID-19 outcomes in persons with hemophilia: results from a US-based national COVID-19 surveillance registry

ISTH Academy, Faculty / Presenters, 409370

Management of chemotherapy-induced thrombocytopenia: guidance from the ISTH Subcommittee on Hemostasis and Malignancy

ISTH Academy, , 409369

Timely identification for long-term impairment: a step further for postpulmonary embolism patients

ISTH Academy, , 409368

Evidence-based personalized thromboprophylaxis after major arthroplasty: a new horizon

ISTH Academy, Faculty / Presenters, 409367

Decoding thrombosis through code: a review of computational models

ISTH Academy, David Bark, 409366

Platelet-targeted gene therapy induces immune tolerance in hemophilia and beyond

ISTH Academy, , 409365

Thromboinflammation in acute injury: infections, heatstroke, and trauma

ISTH Academy, Faculty / Presenters, 409364

Tissue factor at the crossroads of coagulation and radiation response in glioblastoma

ISTH Academy, Faculty / Presenters, 409363

Moving

ISTH Academy, Faculty / Presenters, 409362

Issue Information

ISTH Academy, Faculty / Presenters, 409361